A Phase II Study Of Perifosine (D-21266) In Previously Untreated Patients With Metastatic Or Recurrent Malignant Melanoma.
Latest Information Update: 07 Aug 2023
At a glance
- Drugs Perifosine (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions; Therapeutic Use
- 26 Sep 2005 New trial record.